1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Alkali Metals Ltd.

Alkali Metals Ltd.

80.00
INR
-3.04
(-3.66%)
1.05EPS
78.41P/E
835.17MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
64.86
67.21
71.97
56.71
63.23
69.15
68.91
54.38
90.47
84.83
80.83
80.84
91.34
88.37
Basic EPS, GAAP
-1.93
0.28
2.21
0.35
1.28
1.66
1.23
-1.19
3.46
2.86
1.11
-5.7
0.55
1.05
Free Cash Flow per Basic Share
-4.93
6.58
7.55
2.95
3.93
3.92
5.53
-2.24
8.24
7.9
4.48
3.87
2.46
- -
Dividend per Share
1
- -
1.2
0.48
0.6
1.21
2.65
- -
0.87
2
2
1
0.5
- -
Book Value per Share
49.82
48.49
49.74
49.62
50.46
51.1
49.38
48.48
51.15
51.92
50.43
43.73
43.89
- -
Tangible Book Value per Share
49.16
47.97
49.36
49.3
50.21
50.91
49.26
48.42
51.15
51.92
50.43
43.73
43.89
- -
Basic Weighted Avg Shares
10
10
10
10
10
10
10
10
10
10
10
10
10
10
Sales/Revenue/Turnover
660
684
733
577
644
704
702
554
910
864
823
823
930
900
Operating Margin (%)
-0.18
8.19
8.44
6.38
5.56
5.82
4.79
5.16
8.27
6.51
5.27
-5.44
5.71
3.22
Depreciation Expense
35
43
38
36
35
34
34
33
39
43
46
41
29
28
Net Income, GAAP
-20
3
23
4
13
17
13
-12
35
29
11
-58
6
11
Effective Tax Rate (%)
- -
6.64
24.48
8.42
0.03
- -
- -
647.89
30.86
22.67
27.25
- -
83.22
54.7
Profit Margin (%)
-2.97
0.41
3.08
0.61
2.03
2.4
1.79
-2.18
3.82
3.37
1.37
-7.05
0.6
1.18
Working Capital
27
7
-33
-5
22
39
38
81
88
61
72
7
62
- -
LT Debt
164
99
14
17
8
8
20
37
20
52
39
2
- -
- -
Total Equity
507
494
506
505
514
520
503
494
521
529
513
445
447
- -
Return on Invested Capital (%)
- -
0.35
6.24
4.32
4.97
5.83
- -
-20.96
7.18
5.79
3.78
- -
1.46
- -
Return on Capital (%)
- -
5.32
6.37
3.98
5.22
6.16
- -
-20.61
7.5
6.7
3.89
- -
1.36
- -
Return on Common Equity (%)
-3.79
0.57
4.51
0.7
2.56
3.27
2.45
-2.42
6.86
5.55
2.17
-12.1
1.25
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
181
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
820
485
835

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
532
- -
Cash, Cash Equivalents & STI
- -
13
- -
Accounts Receivable, Net
- -
194
- -
Inventories
- -
288
- -
Total Current Liabilities
- -
470
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
181
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.12%
-1.76%
0.37%
Free Cash Flow
-68.78%
-112.07%
-36.5%
Net Income, GAAP
-119.54%
-237.87%
-109.6%
Sales/Revenue/Turnover
4.58%
13.51%
13%
Total Cash Common Dividend
- -
- -
-50%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
147
205
223
249
823
2026
206
188
249
287
930
2027
176
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-3.27
-1.86
-4.85
4.28
-5.7
2026
-1.13
-0.9
-1.37
3.94
0.55
2027
-0.63
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1
2026
- -
- -
- -
- -
0.5
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Srirama Venkata Rao Yerramilli
Full Time Employees
105
Sector
Process industries
Industry
Chemicals: specialty
Address
Survey No 299 -302, Plot B-5 Hyderabad TS India 500039
IPO Date
Nov 6, 2008
Website
alkalimetals.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Alkali Metals Limited Alkali Metals Limited manufactures and supplies specialty chemicals, including alkali metal derivatives such as sodium amide, sodium hydride, sodium methoxide, sodium azide and sodium alkoxides; pyridine derivatives and amino pyridines; tetrazoles; cyclic compounds; fine chemicals; and active pharmaceutical ingredients (APIs) like benzocaine and fluconazole, serving the pharmaceutical, agrochemical, biotechnology and electroplating industries. The company, incorporated in 1968 and headquartered in Hyderabad, Telangana, India, operates manufacturing facilities in Hyderabad and Visakhapatnam, Andhra Pradesh, with a presence in India, USA, Canada, Europe and Japan to serve customers across 10 countries. It maintains an ISO 9001 and 14001 certified operation following cGMP standards, supported by an in-house R&D department for process innovation and custom synthesis. Recent developments include receipt of USFDA approval for its Visakhapatnam unit, commercialization of products such as 2,5-DB3MP in 2013 and initiation of API manufacturing, alongside ongoing expansion of its product portfolio exceeding 365 items developed through proprietary technology.